2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N13251
    Verbena Extract
    Verbena Extract is a verbena extract. Verbena Extract is a potential anti-ischemic stroke agent, and its mechanism may be related to IL17A-mediated neuroinflammation regulation..
    Verbena Extract
  • HY-149032
    Kobusine derivative-1
    Kobusine derivative-1 is a Kobusine derivative. Kobusine derivative-1 shows antiproliferative activities against cancer cells.
    Kobusine derivative-1
  • HY-121728
    Langkamide
    Langkamide is a novel hypoxia-inducible factor-2 (HIF-2) inhibitory pyrrolidone alkaloid isolated from the roots and stems of Piper sarmentosum, which inhibits HIF-2 transcriptional activity with an EC value of 14.0μM.
    Langkamide
  • HY-108281
    Enfenamic acid
    Enfenamic acid is a nonsteroidal anti-inflammatory agent and a prostaglandin synthetase inhibitor, inhibiting hepatic gluconeogenesis in Swiss albino mice. Enfenamic acid suppresses wound healing.
    Enfenamic acid
  • HY-W698249
    Ferrous gluconate
    Ferrous gluconate is an orally active iron supplement used in the research of iron deficiency diseases.
    Ferrous gluconate
  • HY-168007
    NSC804515
    NSC804515 is a lead compound for ATPase. NSC804515 can be used in cancer and nervous system related research.
    NSC804515
  • HY-128934
    Antitumor agent-2
    Antitumor agent-2 is sourced from patent CN102250203, compound 6a-r, has antitumor action and anti-inflammatory action.
    Antitumor agent-2
  • HY-N9311
    2,3-Dihydroxy-4-methoxybenzoic acid
    2,3-Dihydroxy-4-methoxybenzoic acid is a compound isolated from extracted from sweet cherry fruits (Prunus avium).
    2,3-Dihydroxy-4-methoxybenzoic acid
  • HY-P991636
    AK006
    AK006 is a humanized IgG1 monoclonal antibody agonist targeting Sialic acid-binding immunoglobulin-like lectin6 (Siglec-6). AK006 potently inhibits IgE-mediated human mast cell activation. AK006 can be used for inflammatory diseases like chronic urticaria (CU) and asthma research.
    AK006
  • HY-100194
    FKK
    FKK is an indazole derivative and also a novel bronchodilator.
    FKK
  • HY-N9158
    15,16-Dinor-8(17),11-labdadien-13-one
    15,16-Dinor-8(17),11-labdadien-13-one (compound 3) is a compound isolated from the aerial part of Hedychium coronarium.
    15,16-Dinor-8(17),11-labdadien-13-one
  • HY-W040276
    Diafen NN
    Diafen NN is an antioxidant. Diafen NN induces leukoses and local sarcomas in mice. .
    Diafen NN
  • HY-65039A
    rel-Boc-Hyp-OMe
    rel-Boc-Hyp-OMe is the isomer of Boc-Hyp-OMe (HY-65039), and can be used as an experimental control. Boc-Hyp-OMe is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Boc-Hyp-OMe is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
    rel-Boc-Hyp-OMe
  • HY-155380
    Antiproliferative agent-41
    Antiproliferative agent-41 (compound 14) is a antiproliferative agent indanorine.
    Antiproliferative agent-41
  • HY-115960
    Anticancer agent 35
    Anticancer agent 35 (compound 10), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 35 inhibits A549, A431, PACA2 cell growth with IC50s of 18.1 µg/mL, 4.0 µg/mL, 18.9 µg/mL, respectively.
    Anticancer agent 35
  • HY-158251
    BIBD-300
    BIBD-300 is a PARP-1 imaging agent with high affinity for PARP-1. BIBD-300 can accurately localize C6 and U87MG tumors, which can be used for research in the diagnosis of breast cancer, prostate cancer, glioma, and liver cancer.
    BIBD-300
  • HY-131094
    H-Gly-D-Tyr-OH
    H-Gly-D-Tyr-OH is used for the the solid-phase peptide synthesis.
    H-Gly-D-Tyr-OH
  • HY-138058
    AF-CX 921
    AF-CX 921 is a strong antiepileptic drug.
    AF-CX 921
  • HY-N10388
    Copteroside G
    Copteroside G is a bisdesmosidic glycoside isolated from the epigeal part of the Climacoptera transoxana.
    Copteroside G
  • HY-144071
    MurB-IN-1
    MurB-IN-1 (compound 44) is an inhibitor of uridine diphosphate-N-acetylenolpyruvylglucosamine reductase (MurB), with a Kd 3.57 μM. MurB, a target in P. aeruginosa, is an opportunistic infectious agent causing death.
    MurB-IN-1
Cat. No. Product Name / Synonyms Application Reactivity